EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 30, 2022 relating to the consolidated financial statements of Eloxx Pharmaceuticals, Inc., appearing in the Annual Report on Form 10-K of Eloxx Pharmaceuticals, Inc for the year ended December 31, 2022.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 31, 2023
